Italy· 033858022
BALZIDE*112 cps 750 mg
A balsalazide product containing balsalazide, registered in Italy by MENARINI INTERNAT. O.L.S.A, on the national reimbursement list. The same ATC class is registered in 6 of our 19 countries.
Checked against the register on
Informational only — not a medical device.
Where it is registered
Balsalazide is registered in 6 of 19 countries.
Countries holding a registration under ATC A07EC04 (balsalazide), each read from that country’s own register.
- This record: Italy
- 4 of them publish a price we can compare per daily dose
Balsalazide · ATC A07EC04
6 / 19 countries
- Denmark
- Icelandprice
- Italyprice
- Norwayprice
- United Kingdom
- United Statesprice
The record
At a glance
- Active substance
- Balsalazide
- Manufacturer
- MENARINI INTERNAT. O.L.S.A
- Country
- Italy (IT)
- ATC code
- A07EC04
- ATC class
- Balsalazide
- Defined daily dose
- 6.75 g, O
- Reimbursed
- Yes
- Last checked
- June 4, 2026
Packs & prices · 1
1 priced- aic033858022BALZIDE*112 cps 750 mgEUR 47.68
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
212 interactions on record for balsalazide.
Graded by severity as the source publishes them — 15 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Balsalazide · interactions on record
212 records
- 15 severe
- 146 moderate
- 51 info
Most severe, free to view
- CidofovirJ05AB12severe
- Humane Immunglobuline, unspezifisch, extravaskulärJ06BA01severe
- Humane Immunglobuline, unspezifisch, intravaskulärJ06BA02severe
- SirolimusL01EG04severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Balsalazide in 5 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United Statesbalsalazide disodiumZydus Lifesciences Limited
- United KingdomBalsalazide 750mg capsulesMawdsley-Brooks & Company Ltd
- IcelandColazidAlmirall S.A.*
- NorwayColazidAlmirall, S.A.
- SwedenColazid 750 mg Kapsel, hårdAlmirall S.A.
Authorised across Europe · EMA
The same active substance is authorised in 5 EEA countries. Names it is sold under:
- Denmark · Premid
- United Kingdom (Northern Ireland) · Colazide
- Iceland · Colazid
- Norway · Colazid
- Sweden · Colazid
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of the issuing authority. This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/8d8ea0e6-085b-4f7c-a23c-8904c84e6947 GET /v1/drugs/8d8ea0e6-085b-4f7c-a23c-8904c84e6947?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"price": 47.68,
"source": "aifa",
"currency": "EUR",
"strength": "BALSALAZIDE 750MG 112 UNITA' USO ORALE",
"substance": "Balsalazide",
"equivalence_group": "HYA",
"transparency_flag": null
}See everything about balsalazide.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.